Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 189

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 189
---
 ONE Nuclear. Additionally, HVII’s independent directors reviewed and considered these interests during the negotiation of the Transaction and in evaluating and unanimously approving, as members of the HVII Board, the Business Combination Agreement and the Transactions, including the Business Combination. The independent directors of HVII did not retain an unaffiliated representative to act solely on behalf of unaffiliated security holders for purposes of negotiating the terms of the Business Combination Agreement and/or preparing a report concerning the approval of the Business Combination Agreement.

| 124 |

The HVII Board concluded, based on its review of the foregoing considerations as a whole, that the potential benefits that it expected HVII and its stockholders to achieve as a result of the Transactions outweighed the potentially negative factors associated with the Transactions. Accordingly, the HVII Board unanimously determined that the Business Combination Agreement and the Transactions were advisable and in the best interests of HVII and its stockholders. The HVII Board realized that there can be no assurance about future results, including results considered or expected, as disclosed in the foregoing reasons.

Interests of Certain Persons in the Business Combination

When considering the HVII Board’s recommendation that HVII Public Shareholders vote in favor of the approval of the Business Combination Proposal, HVII Public Shareholders should be aware that the Sponsor and HVII’s executive officers, and directors have interests in the Business Combination that may be different from or in addition to (and which may conflict with) the interests of HVII Public Shareholders. These interests include:

| ● | the                                                                                                      
 beneficial ownership of the Sponsor and certain members of the HVII Board and officers of                
 an aggregate of (a) 6,333,333 HVII Class B Ordinary Shares, which were acquired                          
 for an aggregate purchase price of approximately $25,000 prior to the IPO, which shares would            
 likely be worthless if HVII is unable to effectuate an initial business combination by the               
 end of the Completion Window and HVII is therefore required to liquidate, as HVII                        
 Class B Ordinary Shares are not entitled to participate in any redemption or liquidation                 
 of the Trust Account and (b) 500,000 HVII Private Placement Units, consisting of 500,000                 
 HVII Class A Ordinary Shares and 500,000 HVII Rights, which were acquired for an aggregate               
 purchase price of approximately $5 million simultaneously with the consummation of the IPO,              
 which underlying HVII Rights would become worthless if HVII does not complete an initial                 
 business combination within the Completion Window.